Manchester Management

Manchester Management's James Besser this week sent a letter to the company's board and shareholders asserting that management had moved the date of Vermillion's annual meeting to make difficult any action by shareholders dissatisfied by the poor performance of the firm's stock.

An exchange this week between Vermillion and the Boston-based hedge fund that holds a nearly 10 percent stake in the company has exposed a rift between the company's management and one of its largest shareholders.

The shareholder wants to make it easier to make changes to Vermillion's management team and board amid a drop in the company's share price over the past year.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.